Cannabis News

Over 32,000 Cannabis Studies Have Been Published in the Last 10 Years

Published

1 year ago

December 23, 2023

admin

medical marijuana studies 32,000

Dispelling the Myth of Not Enough Research

When opponents of cannabis law reform run out of reasoned arguments, they inevitably fall back on some version of the “we just don’t know enough yet” appeal. Despite thousands of accumulated years of human experience with cannabis, and an explosion of modern research, prohibitionists claim we must maintain strict controls until every last concern gets addressed. Yet this relies on a mythical standard of absolute knowledge that no policy ever actually meets.

In reality, the argument that cannabis lacks adequate scientific research acts as a thought-terminating cliche allowing people to retain irrational biases. It provides facile cover for those unwilling to examine evidence confronting their beliefs. When one cannot dispute existing data, one demands non-existent alternative data. But as with climate change or evolution, the strength of evidence reaches a point where claiming ignorance becomes absurd. Cannabis surpassed an overwhelming burden of proof long ago.

In fact, over the past decade researchers published over 32,000 cannabis studies, with intense interest and inquiries far outpacing schedules drugs. The mountain of accumulating data continues to fill remaining knowledge gaps at exponential rates, though ideology struggles to keep pace with implications. At this point the rate-limiting factor in comprehending cannabis is not the science but rather acknowledging its conclusions.

Put simply, there is more than enough cannabis research out there for even the most stubborn skeptic or ersatz concern troll. Vague dismissals that “we just don’t know” constitute willful ignorance, not responsible caution. Those making blank appeals against cannabis reform due to lack of research betray the fact that they simply haven’t bothered performing even cursory literature reviews. Their opinions reside firmly in scientific illiteracy and psychological denial.

Today we will explode once and for all the story that humanity lacks ample data to form sensible cannabis policies. In fact the bulk of evidence signals it is prohibition causing net harm, not cannabis itself. The myth contains no clothes.

When examining the modern research record, the claim that cannabis possesses no medical utility becomes increasingly absurd and dishonest. The peer-reviewed literature now includes over 36,000 papers specifically referencing the plant and its components – with over 32,000 published in just the past decade alone as clinical interest intensifies. This proliferation of new data contradicts any suggestion that experts lack adequate scientific understanding of marijuana’s risks and therapeutic potentials.

In reality, some of the world’s top hospitals and research centers continue expanding investigations into cannabis-based treatments for conditions ranging from autism to cancer. The plant’s complex pharmacology reveals diverse medical applications, not simplistic legal categorizations based on an alleged lack of benefit coupled with exaggerated harms. No legitimate reading of marijuana science in the 21st century could reasonably uphold such distorted conclusions rooted in obsolete cultural biases rather than facts.

The range of conditions referenced in the table of contents of this article demolition the notion that cannabis possesses no medical utility. We see specific cannabinoid compounds demonstrating effects as medications for gastrointestinal, neurodegenerative, autoimmune, anxiety and chronic pain disorders among others. The versatility of cannabis to potentially treat such varied conditions simply does not occur with compounds lacking real therapeutic potential.

And while risks exist for a small subset of consumers, these concerns do not outweigh extensive documentation of benefits – otherwise legal pharmaceuticals like opioids and amphetamines could not maintain FDA approval. In contrast, no clinical literature verifies claims that, for adults, cannabis’ potential for harm outweighs its far greater probability to improve quality of life when judiciously applied.

Acknowledging these facts explains why human use persists throughout recorded history regardless of legal regimes. If prohibition’s medical premise was accurate, such relentless experimentation and innovation would collapse from lack of value. That decades of violence enforced via policing and prison did nothing to deter personal experience exposes the sheer futility of fabricating false narratives about cannabis’ relationship to human thriving.

In fact, the US government itself disproves its own medical misinformation by distributing medical cannabis to select patients for nearly 50 years through the Compassionate Investigational New Drug program, though obstruction limited participants to less than three dozen. Challenging this charade reveals not recalcitrance to truth but allegiance to reason the federal denial cannot hide from indefinitely.

The verdict is in; cannabis unambiguously possesses highly significant therapeutic properties for various conditions along with moderate risks researchers work diligently to characterize and mitigate. No defensible argument grounded in science rather than outdated pathology can pronounce otherwise.

Even hypothetically classifying cannabis as categorically “dangerous” fails to ethically justify its prohibition. In a society premising respect for individuals on preserving their self-ownership, competent adults reserve rights to informed consent regarding activities with intrinsic hazards. Hence government lacks legitimate authority to arbitrarily censor choices concerning one’s own body, life benefits and risks resting solely with the individual. Legally and philosophically, paternalistic arguments to forcibly “protect people from themselves” prove both disastrous and self-contradictory.

Consider that dangerous yet legal drugs like alcohol kill tens of thousands annually through direct use while cannabis kills no one. Yet broadcast promotion glamorizes booze consumption to all ages despite predictable casualties and violence from excess. Conversely the state employs force to prevent cannabis ingestion though its acute toxicity is essentially nil. Any consistency in alleged “public safety” arguments collapses when directly comparing reactions to demonstrably more harmful yet condoned behaviors.

Blanket Drug War criminalization shreds the very notion of a free society by demolishing boundaries restraining government imposition on personal conduct. If agents can storm private property at gunpoint to halt commerce in universally safer psychoactive herbs, no genuine limits against state intrusion exist at all. And absent set limitations structurally restraining state power over personal choices, no meaningful rights remain to distinguish despotism from democracy – including in facets of life beyond drugs.

Hence the question becomes where to cease useful pretenses that overriding consent “protects” rather than destroys freedom itself. At what point do unexpected risks lose relevance alongside the right to direct one’s own life? And is it morally preferable to normalize overwhelming force removing self-direction rather than upholding agency to consider options beyond confirmation bias? The ramifications span far beyond cannabis alone.

Perhaps risks reach points drastic enough in rare outlier cases like imminent suicide ideation that intervention against one’s will acts as lesser evil, though defining such exceptions requires immense diligence. But cannabis remotely approximates no such pressing crisis; it facilitates life enhancement, creative pursuits, medical substitution, and spirituality for most citizens. And even misuse flowing from legal access poses orders of magnitude less damage than the status quo’s violence and life-derailment.

So whether one believes cannabis objectively harmless or laden with abuse potential, the bedrock ethical principle of self-ownership precludes its prohibition. Only by gaping logical inconsistencies can a society dismiss bodily autonomy selectively. And defending agency – the power to control one’s body and claim the benefits and consequences of their actions – remains prerequisite for defending rights at all. Recreational foliage fails any rational threshold where forced “protection” from optional experimentation outweighs the cost to human dignity from intrusion. Thus ethics demands legality either way.

The theater of cannabis prohibition strains any pretense that modern policies intend to serve common welfare over insider interests. As public majorities continuously favor reform yet find their preferences ignored and overridden, the veil lifts on who truly dictates the status quo – and it assuredly does not include average citizens. When the many acquiesce to the few wielding power against them, dynamics of control rather than representation govern the state.

The relentless suppression of cannabis reveals profound distrust toward people governing their own lives, not danger legitimizing subjugation. This pathological need for command and obedience perverts democratic self-rule into tyranny of the majority codified via police and prisons. Rather than empower insight or responsibility, instituted powers demand compliance and sacrifice instead – they serve citizens no benefit beyond nominal “protection” from their own agency.

We witnessed similar dynamics when credentialed experts faced censorship for challenging pandemic narratives enabling enormous pharmaceutical profits. Their dissent threatened not public health but elite prerogatives couched as doing good. Prohibiting peaceful choices while encouraging genuine poisons exposes the ruse – no factual basis supports equating cannabis with deadly legal drugs, let alone banning the natural herb. Such contradictory stances serve financial interests above rights or safety. And violated rights signal inner machinery of democracy broken beyond repair.

When “public policy” directly contravenes public opinion yet remains entrenched by authorities never subjected to elections, the will of common people lacks any effective representation. Their place becomes pliant masses ruled by technocrats, political dynasties and corporate oligarchies. Issues like cannabis uncover how modern states suppress populaces within systems promising self-determination on paper.

Therefore ending prohibition occupies importance far exceeding the herb; it signifies reclaiming policymaking levers for citizens themselves against inertia of embedded powerful interests. Truly representative governance cannot blithely overrule supermajority public consensus on any issue indefinitely with impunity, lest it loses legitimacy as anything beyond glorified dictatorship wearing superficial regalia.

In that context, cannabis offers opportunity to prove principles of self-rule still animate democratic lifeblood. Or conversely, upholding its historically unprecedented and scientifically baseless banning in defiance of public opinion demonstrates a Potemkin village where ordinary voices assemble formally but wield no influence. Either civil majorities reclaim authority over their collective destiny, or the grand experiment in distributed authority fails entirely, ceding to structures of top-down population management mouthing vacuous nostrums about “freedom.”

Elucidating the futility of cannabis prohibition aims not to overwhelm but to empower. By exposing the façade, we shine light through cracks revealing paths forward. Truth sets possibility free, beginning within each individual.

The founding vision for this nation anchored in principles of open discourse, autonomy and self-governance. Though imperfectly practiced, these ideals birthed most prosperous societies in human history. They remain guidelines worth fighting for.

Yet the game stays rigged only when we accept rigged rules. We need not play games fixed against us, but gather collective courage to assert rules representing our shared interests. Mass refusal of unjust laws peacefully nullifies their power. And courage stands contagious – when communities defend reason over coercion, hope ignites.

The state cannot operate without public complicity. Its sole purpose ought to uphold freedoms enabling citizens to thrive through self-direction. Any structures systematically overriding agency toward those ends no longer serve common humanity, but metastasize as tyranny dressed in familiar branding.

Our role lies not in violent revolution, but non-violent evolution toward systems facilitating empowerment.

We abandon assumptions that central authorities best solve local problems. Instead we work locally to prove mass flourishing blossoms when all lead themselves. The game only felt rigged when we forgot our place as players, not pawns.

The board resets when we make different moves.

MEDICAL MARIJUANA RESEARCH, READ ON…

7 SCIENTIFIC MARIJUANA STUDIES THAT SHOW CANNABIS IS SAFE!

Source link

Cannabis News

What if the World’s Biggest Tobacco Company Entered the Cannabis Industry?

Published

3 hours ago

February 1, 2025

admin

philip morris marijuana

The World’s Biggest Tobacco Company Is Quietly Entering The Weed Industry

What Does This Mean For The Future Of Weed?

From the 1950’s to the 1990’s, cigarettes were considered to be a ‘cool’ habit and somewhat of a fashion accessory globally.

There was even a time when Hollywood celebrities were photographed smoking, which made them seem like the epitome of sophistication. Big names including Humphrey Bogart and James Dean were pictured smoking, but it was also so common and accepted around the world. That did not last long, as eventually evidence that cigarettes killed people from cancer and other fatal health conditions became impossible to ignore.

While there were many names in Big Tobacco that helped popularize the consumption of cigarettes, and made it easy for people to get access to it, Philip Morris International (PMI) were one of the biggest players – and they still are, to this day. They own some of the most common cigarette brands that are consumed around the world, including Marlboro, Chesterfield, and L&M. Surely, one can blame PMI’s products for tempting people to make poor health choices that may have taken them to the grave…

According to the World Health Organization, tobacco smoking is responsible for the deaths of around 8 million people globally.

Yet, with the rise of cannabis, PMI wanted a piece of the pie.

The History Of Philip Morris’ Interests In Cannabis

If you’re only hearing about Big Tobacco’s interest in cannabis right now, you might be shocked to learn that their interest in weed goes as far back as 1969. There are some internal documents that prove PMI was interested in learning about the potential of cannabis. However, they were considering weed a competitor as well as a potential product.

In fact, a 1970 memo even shows that PMI acknowledges the possibility of marijuana legalization.

Fast forward to 2016, when PMI made a significant investment worth $20 million to an Israeli biotech firm specializing in medical cannabis, called Syqe Medical. At the time, Syqe was working on developing a medical marijuana inhaler which would provide metered dosing of weed for medical patients. According to the deal, Syqe Medical will also work on developing certain technologies that would enable Philip Morris to minimize the health effects caused by smoking.

By 2023, Philip Morris made a deal to acquire Syqe Medical for a cool $650 million, as long as there were certain conditions met. In a report by Calcalist, the deal features a number of milestones, though the bottom line is that if the inhaler developed by Syqe passes the clinical trials, PMI will then go ahead to buy all shares of the company for the aforementioned amount.

Another Silent Move Into The Weed Space

More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna.

According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry. Back in 2016, when they first got involved with Syqe Medical, it highlighted the firm’s interest in wellness, but the partnership with Avicanna cements that.

Changes In Consumer Perception And Habits

It only makes sense for Big Tobacco to pivot to cannabis – or wellness, in general. After all, if you can’t beat em, join em!

And it’s clear: for several years now, there has been a decrease in cigarette smoking; young adults are now shifting from tobacco, as well as alcohol, and increasing their cannabis consumption instead.

And Philip Morris isn’t the only player in Big Tobacco who’s expressed an interest in a slice of the (weed) pie. Back in 2017, American holding company Altria Group began moving away from cigarettes, with their $1.8 billion investment into the Cronos Group, a large Canadian cannabis company. Altria owns several big American companies including Philip Morris; so much so, that even their website now declares the tagline: “Moving Beyond Smoking”.

However, Altria faced issues due to regulatory concerns.

British American Tobacco (BAT) has also been interested in cannabis. For some time now, they’ve been researching weed products, particularly infusing CBD and THC into their electronic cigarettes which are sold under the Vuse and Vype brand names. In 2021, BAT began a trial launch of CBD products in the United Kingdom.

RJ Reynolds, which is also now under British American Tobacco, has also considered joining the weed industry. According to internal documents, RJ Reynolds has considered cannabis both an opportunity and a competitor as far back as the 1970s.

Conclusion

At the end of the day, cannabis isn’t a real threat to the tobacco industry. The tobacco industry simply shot itself on the foot – all it needed was time, to prove that it does indeed cause cancer and kill people. On the other hand, cannabis was a friend more than a foe: legalization and a growing consumption of weed proved its ability to save lives.

That said, the relationship between tobacco and weed continues to evolve. Through cannabis legalization, Big Tobacco can learn from the challenges and opportunities that cannabis had to go through. It can be said that one thing is clear, though: the drop in tobacco consumption is a major opportunity for cannabis, with more people looking to substitute tobacco with a healthier alternative.

As a response, we may continue to see tobacco companies investing in Big Cannabis – just as we’ve seen in the examples mentioned above. This partnership is fantastic news for both industries, and we can only hope to see more!

PHILIP MORRIS’ MOVES IN CANNABIS, READ ON…

WHY DID PHILIP MORRIS JUST BUY A MEDICAL MARIJUANA INHALER COMPANY?

Source link

Cannabis News

Who are the Next 5 States to Legalize Recreational or Medical Cannabis Starting in 2025?

Published

1 day ago

January 31, 2025

admin

next states to legalize

As the landscape of marijuana legalization continues to evolve across the United States, 2025 is shaping up to be a pivotal year for states considering reforms. Advocacy groups are closely monitoring legislative developments and public sentiment, identifying specific states that are likely to make significant strides toward legalization. This article explores the states most likely to legalize marijuana in 2025, examining the political climate, public opinion, and advocacy efforts that may influence these changes.

The Current State of Marijuana Legalization in the U.S.

As of 2023, a growing number of states have legalized marijuana for both medical and recreational use. According to the National Conference of State Legislatures (NCSL), 21 states and Washington D.C. have legalized recreational marijuana, while 37 states allow medical marijuana use. This rapid expansion reflects changing public attitudes toward cannabis, which have shifted dramatically over the past two decades.

Public Opinion Trends

Public support for marijuana legalization has reached unprecedented levels. A Gallup poll conducted in late 2022 found that 68% of Americans support legalizing marijuana, a significant increase from just 25% in 1995. This shift in public opinion is crucial for lawmakers as they consider new legislation. Advocacy groups are leveraging this support to push for reforms in states where legalization has yet to occur.

The Role of Advocacy Groups

Organizations such as the National Organization for the Reform of Marijuana Laws (NORML) and the Marijuana Policy Project (MPP) play a vital role in advocating for legalization. They provide research, mobilize grassroots campaigns, and lobby lawmakers to promote cannabis reform. Their insights into which states are most likely to legalize in 2025 are based on legislative trends, political dynamics, and public sentiment.

Key States Likely to Legalize Marijuana in 2025

Pennsylvania has emerged as a strong contender for marijuana legalization in 2025. The state has a robust medical marijuana program established in 2016 that has seen significant success, with over 600,000 registered patients. However, advocates argue that the time has come to expand access to adult-use cannabis.

Political Support

The recent election of Governor Josh Shapiro has energized legalization efforts. Shapiro has expressed support for legalizing recreational marijuana and has indicated a willingness to work with lawmakers across party lines. In early 2025, a bipartisan bill is expected to be introduced that aims to create a regulated market for adult-use cannabis.

Advocacy Efforts

Advocacy groups are actively mobilizing support among residents and lawmakers alike. Campaigns highlighting the potential economic benefits—such as job creation and tax revenue—are gaining traction. Additionally, public polls indicate strong support among Pennsylvanians for legalization, further bolstering advocacy efforts.

Hawaii has long been known for its progressive stance on cannabis; it was one of the first states to legalize medical marijuana in 2000. However, efforts to legalize recreational use have stalled in previous legislative sessions.

Current Developments

In 2025, advocates are optimistic about renewed efforts to pass comprehensive cannabis legislation. The Senate previously approved a bill aimed at legalizing recreational use, but it failed in the House due to opposition from conservative lawmakers.

Political Dynamics

The political landscape appears more favorable this year with new leadership in the House that may be more open to discussing cannabis reform. Governor Josh Green has also expressed support for legalization, emphasizing its potential economic benefits for Hawaii’s tourism-driven economy.

Advocacy Strategies

Advocacy groups are focusing on grassroots campaigns and community engagement to build momentum for legalization. Public forums and educational events aim to inform residents about the benefits of legalization while addressing concerns regarding regulation and safety.

South Carolina has made strides toward medical marijuana legalization but remains one of the few states without comprehensive access to cannabis products. In recent years, lawmakers have introduced several bills aimed at establishing a medical program; however, these efforts have faced significant hurdles.

Legislative Prospects for 2025

In 2025, advocates are hopeful that a revived medical marijuana proposal will gain traction. The proposed legislation would allow patients with qualifying conditions access through licensed pharmacies under strict regulations.

Political Climate

The political climate remains challenging, with resistance from conservative factions within the legislature. However, increasing public support—evidenced by recent polls showing over 70% approval for medical cannabis—may sway some lawmakers toward supporting reform.

Advocacy Efforts

Advocacy organizations like SC Compassionate Care are working tirelessly to educate the public and legislators about the benefits of medical marijuana. They emphasize patient stories and health outcomes as part of their strategy to garner support.

Kansas is one of the few remaining states without any form of legalized marijuana use. Despite this restrictive environment, there is a growing movement advocating for medical cannabis legislation.

Legislative Opportunities

In 2025, advocates believe there is a significant opportunity for progress on medical marijuana legislation. Several bills have been introduced in previous sessions that gained some bipartisan support but ultimately failed due to opposition from key lawmakers.

Public Sentiment

Public opinion in Kansas is shifting; recent surveys indicate that nearly 60% of residents support legalizing medical marijuana. This growing acceptance may influence legislators who have previously opposed reform.

Advocacy Strategies

Groups like Kansas Cannabis Coalition are actively campaigning for change by organizing rallies and educational events throughout the state. They aim to raise awareness about the therapeutic benefits of cannabis while pushing for legislative action.

North Carolina has been making headlines regarding potential cannabis reform. While it currently allows limited use of CBD oil for certain medical conditions, comprehensive medical or recreational legalization remains elusive.

Political Dynamics

In recent years, there have been increased discussions among lawmakers about introducing medical marijuana legislation. The current governor supports reform efforts; however, opposition from conservative members poses challenges.

Advocacy Efforts

Advocacy groups such as NC NORML are working diligently to build grassroots support for legalization initiatives. They focus on educating citizens about cannabis benefits while lobbying legislators directly.

Wisconsin’s approach toward cannabis remains conservative compared to neighboring states like Illinois and Michigan. While some local municipalities have decriminalized possession or implemented medicinal programs at their discretion, comprehensive statewide reform is still lacking.

Legislative Prospects

Advocates believe that changing political dynamics could lead Wisconsin toward more progressive policies regarding both medical and adult-use legalization by 2025. Recent elections have resulted in a more favorable balance within state government regarding cannabis issues.

Public Support

Public opinion polls indicate strong support among Wisconsinites—over 60% favoring legalization efforts—creating an opportunity for advocates seeking legislative change.

Advocacy Strategies

Organizations like Wisconsin NORML are mobilizing citizens through educational campaigns aimed at dispelling myths surrounding cannabis while promoting its economic benefits through taxation and job creation associated with regulated markets.

New Hampshire has long been considered an outlier among New England states regarding cannabis laws; it legalized medical marijuana back in 2013 but has yet to pass adult-use legislation despite numerous attempts over recent years.

Current Developments

In early 2025, advocates anticipate renewed efforts aimed at legalizing recreational use through proposed bills introduced during legislative sessions scheduled throughout spring months ahead.

Political Climate

While there is bipartisan interest among some legislators regarding potential reforms related specifically towards taxation structures associated with regulated markets—opposition remains strong from conservative factions within government bodies overall limiting chances significantly unless public pressure mounts significantly enough leading into future elections cycles ahead!

Virginia made headlines when it legalized recreational cannabis possession starting July 1st ,2021—but sales remain unregulated until further action occurs within state government bodies responsible overseeing these matters moving forward!

Legislative Prospects

Advocates believe that enhancing existing laws by adding regulated sales will be crucial steps towards creating an effective market structure benefiting consumers while generating tax revenue needed fund essential services statewide!

Conclusion

As we look ahead into 2025—the landscape surrounding marijuana legalization continues evolving rapidly across various states nationwide! With growing public support coupled alongside advocacy group efforts pushing forward reforms—it’s clear many opportunities exist within multiple jurisdictions ripe opportunities await those willing engage actively participate shaping future policies governing this vital industry.

WHAT STATES MAY NEVER LEGALIZE WEED, READ ON…

WHAT STATES MAY NEVER LEGALIZE WEED, HERE ARE 4 IDEAS!

Source link

Cannabis News

Emotional Regulation Get Easier with Cannabis?

Published

2 days ago

January 30, 2025

admin

emotional regulation with cannabis

Emotional regulation refers to an individual’s ability to manage to various emotional stimuli in an appropriate manner.

When one is able to regulate their emotions, it means that they are able to withhold intense and extreme emotions, even when the situation normally calls for it. As a result, they are able to express their emotions in a proper way; it is controlled but not suppressed, it’s mindful and aware. Effective emotional regulation has been linked to emotional maturity, better relationships, and an improvement in overall well-being.

However, using certain drugs as well as alcohol have proven to negatively impact one’s ability to regulate their emotions. This is because drugs engage with the neurotransmitters in the brain, including those responsible for the production of serotonin and dopamine, which are necessary for healthy emotional regulation. When we consume central nervous system depressants such as alcohol, as well as stimulants in drugs, these severely impede our serotonin levels which can cause depression and other mental health issues. In addition, drugs have been found to affect emotional dysregulation and dependence.

But not cannabis.

According to the results of a clinical study conducted by researchers at the Oregon State University and Washington State University, inhaling weed containing over 20% THC was not found to have any impact on emotional regulation.

For the study, investigators analyzed the effects of weed smoking on 12 adults; all the participants already had experience smoking weed in the past and even used their own cannabis supply. The researchers then analyzed the mood and emotional regulation capabilities of the participants during times of sobriety as well as when they were stoned from weed. Surprisingly, they found that the subjects’ performance didn’t differ when made to undergo several tasks after smoking weed.

“There was no evidence that acute high-potency cannabis use affected participants’ implicit or explicit emotional regulation,” they said. The researchers also noted that the participants acknowledged there was an improvement in their mood and anxiety reduction after using weed.

“The current pilot study assessed whether being under the influence of high-potency cannabis flower affects emotion regulation among a sample of young adults who use cannabis regularly,” they concluded. “While participants reported more positive mood and decreases in anxiety while intoxicated, there was no evidence to suggest that intoxication from high-potency cannabis flower affected emotion regulation,” the researchers wrote.

How Else Can Cannabis Benefit Emotional Health?

Thousands of people rely on cannabis for its benefits on their emotional and mental well-being. In fact, most cannabis consumers have a positive association with cannabis and emotions, since it can effectively help them reduce encounters of negative emotions in general. For example, instead of ruminating in stress and worry, people can medicate with weed at the end of the day. This not only aids in relaxation, but also offers a natural, safe outlet for coping with the stresses of everyday life.

In the same vein, this is also why more individuals, particularly those in high-stress positions such as parents, CEO’s, and entrepreneurs, have made microdosing or getting high a part of their daily life. No longer is alcohol seen as the only way to cope: weed is in, and it’s a much healthier way of dealing with life.

While this may be something that science can’t explain just yet, cannabis does have the unique ability to slow down one’s racing thoughts and the endless mental chatter, while helping make it easier to focus on the present. For this reason and more, weed has already been widely integrated into many wellness retreats in legal cities. Weed, mindfulness, and yoga simply go together so well, enhancing the peaceful effects of one another. Cannabis consumers can also enjoy a great deal of relaxing activities with a heightened sense of enjoyment, effectively helping one forget about their negative emotions such as anger, stress, and frustration.

So the next time you’re feeling extremely irritable or pissed off, why not pop a gummy or have a toke, and spend some time outside. You’ll see how difficult it can be to stay mad.

What You Take Matters

For those who want to use cannabis to improve their emotional regulation, what you take – and how much of it – matters just as much too.

That’s why there are many more studies suggesting that low-dose THC is best especially for anxiety and stress. On the other hand, high doses of THC can be detrimental for your mental and emotional well-being.

According to a 2017 study conducted by researchers at the University of Illinois at Chicago and the University of Chicago: “We found that THC at low doses reduced stress, while higher doses had the opposite effect, underscoring the importance of dose when it comes to THC and its effects,” they said. The same is also true for psychedelics, which can partly explain the popularity of microdosing psychedelics. Meanwhile, anything that can you too high can in fact, cause intense anxiety and stress.

Conclusion

It can feel almost impossible to avoid stressful situations that can cause you to feel out of whack, emotionally. In fact, stress is just a normal part of life. But losing your temper, ruminating in negative emotions for hours, and being so upset that it affects other aspects of your life, is not normal.

That said, there are a variety of ways you can deal with stress and the negative emotions it brings. Cannabis can be a key ingredient for helping you restore balance in your emotions as well as mental health.